GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Li Kang Biomedical Co Ltd (ROCO:6242) » Definitions » Additional Paid-In Capital

Li Kang Biomedical Co (ROCO:6242) Additional Paid-In Capital : NT$213.4 Mil(As of Mar. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Li Kang Biomedical Co Additional Paid-In Capital?


Li Kang Biomedical Co's quarterly additional paid-in capital stayed the same from Sep. 2023 (NT$33.7 Mil) to Dec. 2023 (NT$33.7 Mil) but then increased from Dec. 2023 (NT$33.7 Mil) to Mar. 2024 (NT$213.4 Mil).

Li Kang Biomedical Co's annual additional paid-in capital increased from Dec. 2021 (NT$33.7 Mil) to Dec. 2022 (NT$33.7 Mil) and increased from Dec. 2022 (NT$33.7 Mil) to Dec. 2023 (NT$33.7 Mil).

Li Kang Biomedical Co Additional Paid-In Capital Historical Data

The historical data trend for Li Kang Biomedical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Li Kang Biomedical Co Additional Paid-In Capital Chart

Li Kang Biomedical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.63 33.63 33.72 33.72 33.75

Li Kang Biomedical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.75 33.75 33.75 33.75 213.39

Li Kang Biomedical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Li Kang Biomedical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Li Kang Biomedical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Li Kang Biomedical Co (ROCO:6242) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Li Kang Biomedical Co Ltd (ROCO:6242) » Definitions » Additional Paid-In Capital
Comparable Companies
ROCO:2734 ROCO:6961 ROCO:2745 ROCO:2743 ROCO:2719 TPE:5706 BKNG ABNB XMAD:AMS TCOM RCL CCL EXPE NCLH HKSE:00780 MMYT XPAR:MMB LSE:JET2 ASX:FLT TNL
Traded in Other Exchanges
N/A
Address
No.29, Huangong Road, Yongkang District, Taipei City, TWN, 71041
Website
http://www.likangbio.com
Li Kang Biomedical Co Ltd is a Taiwan based company engages in tourism factory businesses, telemarketing, as well as the manufacturing and sales of cosmetics and hygienic drinks.

Li Kang Biomedical Co (ROCO:6242) Headlines

No Headlines